QCG
EDIT icon

Quadrant Capital Group’s Editas Medicine EDIT Stock Holding History

Quadrant Capital Group’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,417
Closed -$11.7K – 2752
2024
Q3 		$11.7K Buy
3,417
+2,005
+142% +$8.73K ﹤0.01% 2099
2024
Q2 		$6.59K Buy
1,412
+85
+6% +$479 ﹤0.01% 2231
2024
Q1 		$9.85K Hold
1,327
– – ﹤0.01% 2112
2023
Q4 		$13.4K Buy
+1,327
New +$11.6K ﹤0.01% 1958
2023
Q2 		– Sell
-1,526
Closed -$11.1K – 2713
2023
Q1 		$11.1K Buy
1,526
+1,341
+725% +$11.9K ﹤0.01% 1991
2022
Q4 		$1.64K Buy
+185
New +$2.03K ﹤0.01% 2466
2022
Q1 		– Sell
-18
Closed – – 2539
2021
Q4 		$0 Sell
18
-156
-90% -$5.37K ﹤0.01% 2553
2021
Q3 		$7K Buy
174
+156
+867% +$8.55K ﹤0.01% 1743
2021
Q2 		$1K Hold
18
– – ﹤0.01% 2248
2021
Q1 		$1K Hold
18
– – ﹤0.01% 2203
2020
Q4 		$1K Hold
18
– – ﹤0.01% 2092
2020
Q3 		$1K Buy
+18
New +$586 ﹤0.01% 1954
2020
Q2 		– Sell
-10
Closed – – 2263
2020
Q1 		$0 Buy
+10
New +$252 ﹤0.01% 2149

Other funds holding EDIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Quadrant Capital Group's EDIT Position: Q4 2024 in Review

Quadrant Capital Group sold out of Editas Medicine (EDIT) in Q4 2024, closing a stake of 3,417 shares — an estimated $11.7K sold.

Quadrant Capital Group first reported a position in EDIT in Q1 2020 and held it in 13 quarters. The position peaked at $13.4K in Q4 2023. 206 funds tracked by Wall St. Rank hold EDIT as of Q4 2024.

  • Quadrant Capital Group reported no remaining Editas Medicine position as of Q4 2024 after selling out during the quarter.
  • Quadrant Capital Group sold 3,417 Editas Medicine shares in Q4 2024, an estimated $11.7K.
  • Quadrant Capital Group first reported a position in Editas Medicine in Q1 2020 and held it in 13 quarters.
  • Quadrant Capital Group's Editas Medicine position peaked at $13.4K in Q4 2023.
  • 206 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2024.

Based on Quadrant Capital Group's 13F filing for Q4 2024, filed 13 Feb 2025.